The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
The liver is the sixth most common site of primary cancer in humans and the fourth leading
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …
Cancer vaccines
LH Butterfield - Bmj, 2015 - bmj.com
Cancer vaccines are designed to promote tumor specific immune responses, particularly
cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines …
cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines …
[HTML][HTML] Alpha-fetoprotein: Past, present, and future
Alpha-fetoprotein (AFP) is a glycoprotein that plays an important role in immune regulation
with critical involvement in early human development and maintaining the immune balance …
with critical involvement in early human development and maintaining the immune balance …
Progress in human tumour immunology and immunotherapy
SA Rosenberg - Nature, 2001 - nature.com
Studies of the administration of interleukin-2 to patients with metastatic melanoma or kidney
cancer have shown that immunological manipulations can mediate the durable regression …
cancer have shown that immunological manipulations can mediate the durable regression …
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
Abstract α-Fetoprotein (AFP) is a self protein expressed by fetal liver at high levels, but is
transcriptionally repressed at birth. AFP is up-regulated in hepatocellular carcinomas, and …
transcriptionally repressed at birth. AFP is up-regulated in hepatocellular carcinomas, and …
Alpha‐fetoprotein and hepatocellular carcinoma immunity
X Wang, Q Wang - Canadian Journal of Gastroenterology and …, 2018 - Wiley Online Library
Hepatocarcinoma is one of the most prevalent gastroenterological cancers in the world with
less effective therapy. As an oncofetal antigen and diagnostic marker for liver cancer, alpha …
less effective therapy. As an oncofetal antigen and diagnostic marker for liver cancer, alpha …
Liver immunology
The liver is the largest organ in the body and is generally regarded by non-immunologists as
not having lymphoid function. However, such is far from accurate. This review highlights the …
not having lymphoid function. However, such is far from accurate. This review highlights the …
T-cell responses to HLA-A* 0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer
Purpose: An existing immunological paradigm is that high concentrations of soluble protein
contribute to the maintenance of peripheral tolerance/ignorance to self protein. We tested …
contribute to the maintenance of peripheral tolerance/ignorance to self protein. We tested …
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino, C Castelli, G Parmiani - Cancer Immunology, Immunotherapy, 2005 - Springer
The technological advances occurred in the last few years have led to a great increase in
the number of tumor associated antigens (TAA) that are currently available for clinical …
the number of tumor associated antigens (TAA) that are currently available for clinical …
[HTML][HTML] Immunotherapy for hepatocellular carcinoma: a 2021 update
Simple Summary Hepatocellular carcinoma (HCC) is the most common liver malignancy
associated with poor prognosis. Treatment options are limited partially due to resistance to …
associated with poor prognosis. Treatment options are limited partially due to resistance to …